Maher Abdul-Hay

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Venues

Clinical and translational science

Journal of medical case reports

JCO oncology practice

Journal of hematology & oncology

NYU School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU School of Medicine Jul 01 2012

United States

Assistant Professor (Clinical) of Medicine (Academic) :: Medicine

Publications

Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
A Samer Al-Homsi, Frank Cirrone, Stephanie Wo, Kelli Cole, J Andres Suarez-Londono, Sharon L Gardner, Jingmei Hsu, Kelsey Stocker, Benedetto Bruno, Judith D Goldberg, Benjamin A Levinson, Maher Abdul-Hay
PTCy, Abatacept, and Short Course of Tacrolimus for GvHD Prevention Following Haploidentical Transplantation. Blood advances (2023)
Edward Carey, Nicholas Ward, Maher Abdul-Hay
Large granular lymphocytic leukemia cured by allogeneic stem cell transplant: a case report. Journal of medical case reports 16 (1) (2022)
Jennifer Wu, Amin Yakubov, Maher Abdul-Hay, Erica Love, Gianna Kroening, Deirdre Cohen, Christy Spalink, Ankeeta Joshi, Arjun V Balar, Kathie-Ann Joseph, Joseph Ravenell, Janice Mehnert
Prescreening to Increase Therapeutic Oncology Trial Enrollment at the Largest Public Hospital in the United States. JCO oncology practice (2021)
Leonard Naymagon, Maher Abdul-Hay
Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature. Journal of medical case reports 13 (1) (2019)
Leonard Naymagon, Maher Abdul-Hay
Novel agents in the treatment of multiple myeloma: a review about the future. Journal of hematology & oncology 9 (1) (2016)
Helen Ma, Maher Abdul-Hay
T-cell lymphomas, a challenging disease: types, treatments, and future. International journal of clinical oncology 22 (1) (2016)

Maher Abdul-Hay.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maher Abdul-Hay